Grants for Biotech Companies in New York (2026)
New York's biotech ecosystem has grown substantially with LifeSci NYC, the Alexandria Center, and major teaching hospitals (Mount Sinai, Weill Cornell, Columbia, NYU Langone, Memorial Sloan Kettering) anchoring the research pipeline. For bootstrapped NY biotech founders, non-dilutive capital flows primarily through federal NIH SBIR/STTR (with strong application support from NYC hospital research offices), BARDA, CDMRP, and NSF. State-level programs through Empire State Development's Life Sciences Initiative, including tax credits and grant programs, provide additional support. NYCEDC's LifeSci NYC programs fund internship support and incubator infrastructure for NY-based life sciences companies. Private programs include the Simons Foundation (NYC-based), Memorial Sloan Kettering Cancer Center's venture programs, Mount Sinai Innovation Partners, and Columbia Technology Ventures. Y Combinator Bio and IndieBio's NYC sister program add accelerator pathways. Bootstrap Directory aggregates NY-eligible biotech grants across federal, state, and private sources for efficient prioritization by biotech sub-sector (diagnostics, therapeutics, devices, digital health). NY biotech founders leveraging hospital-based clinical pilots alongside NIH SBIR funding can create unusually strong translational evidence packages early.
Last updated
This guide and matching listings are refreshed from the Bootstrap Directory database as source data changes.
Data sources
Sources include Grants.gov, SAM.gov, SBIR.gov, CareerOneStop, state agencies, universities, and verified organizations.
Refresh cadence
Listings are checked weekly where source data allows, with stale or closed programs removed from public results.
Verification
Always confirm eligibility, deadlines, and award details on the official source or application page before applying.
Get alerts for this search
Create a free account, run the matching search, and save it to get new funding, grant, or training updates.
Featured Opportunities
NIH REACH — Research Evaluation and Commercialization Hubs
DoW Neurofibromatosis Synergistic Idea Award
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
DoW Rare Cancers Concept Award
Engineering Biological and Biomedical Systems (EBBS)
DoW Ovarian Cancer, Clinical Trial Award
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats
Frequently Asked Questions
What is LifeSci NYC?
LifeSci NYC is NYCEDC's coordinated initiative to grow the life sciences sector in New York City. It has included internship support programs, incubator infrastructure (like LaunchLabs at NYU and Mount Sinai), and funding for NY-based life sciences companies. It complements federal SBIR/STTR funding rather than replacing it.
Do NY teaching hospitals fund biotech startups?
Major NYC teaching hospitals run innovation programs that fund spin-outs from their research — Mount Sinai Innovation Partners, NYU Langone Innovations, Columbia Technology Ventures, Weill Cornell Enterprise Innovation. These typically combine milestone-based non-dilutive funding with IP licensing and clinical access, which can be very valuable for translational biotech founders.
When are New York biotech grant deadlines?
NIH SBIR solicitations open 3x annually. BARDA, CDMRP, NSF operate on agency-specific cycles. Empire State Development Life Sciences programs vary by fiscal year. Hospital innovation programs have their own cadences. Bootstrap Directory tracks current NY biotech openings across all programs.